Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

NOT YET RECRUITING

NCT06934707

Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes

Sponsor: Hospital de Clinicas de Porto Alegre

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to examine the effect of 3 versus 6 daily meals of isocaloric diets on glycemic control and variability in individuals with type 1 diabetes. Participants will be randomized in a crossover clinical trial and will receive two different types of isocaloric diet interventions, in 3 meals/day (calorie distribution: 30% at breakfast, 40% at lunch and 30% at dinner) or 6 meals/day (calorie distribution: 20% at breakfast, 10% at morning snack, 30% at lunch, 10% at afternoon snack, 25% at dinner and 5% at evening snack), for three weeks, with a 4-week washout period between diets.

Official title: Meal Frequency, Glycemic Control and Variability in Individuals With Type 1 Diabetes: a Randomized Crossover Clinical Trial

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

Start Date

2025-04-20

Completion Date

2027-12-29

Last Updated

2025-04-18

Healthy Volunteers

Conditions

Type 1 Diabetes (T1D)Nutrition Therapy Glycemic Control for Diabetes Mellitus

Interventions

BEHAVIORAL

Three meals a day

This group will follow a dietary prescription consisting of three meals per day. The total energy value will be distributed in accordance with the macronutrient recommendations for type 1 diabetes (T1D), as follows: 45% of energy from total carbohydrates, prioritizing those with a low glycemic index; up to 30% from total fats, with unsaturated fats being the primary source; and 25% of energy from proteins. Caloric distribution will be divided into 30% for breakfast, 40% for lunch, and 30% for dinner, with 14 g of fiber per 1000 kcal distributed across the three meals. Furthermore, the gram amounts of the macronutrient in each meal will be apportioned such that 15-20% of the total carbohydrate intake, 7-10% of the total protein intake, and 10% of the total fat intake.Participants will also be instructed to maintain their habitual physical activity level.

BEHAVIORAL

Six meals a day

This group will follow a dietary prescription consisting of six meals per day. The total energy value will be distributed in accordance with the macronutrient recommendations for type 1 diabetes (T1D), as follows: 45% of energy from total carbohydrates, prioritizing those with a low glycemic index; up to 30% from total fats, with unsaturated fats being the primary source; and 25% of energy from proteins. Caloric distribution will be divided into 20% for breakfast, 10% morning snack, 30% for lunch, 10% afternoon snack, 25% for dinner and 5% bedtime snack, with 14 g of fiber per 1000 kcal distributed across the three meals. Furthermore, the gram amounts of the macronutrient in each meal will be apportioned such that 5-10% of the total carbohydrate intake, 2-7% of the total protein intake, and 2-8% of the total fat intake.Participants will also be instructed to maintain their habitual physical activity level.

Inclusion Criteria: * • Adults (18 to 60 years old) with a medical diagnosis of type 1 diabetes mellitus * Individuals who perform carbohydrate counting * Individuals diagnosed \> 12 months ago * Perform daily glycemic control using a blood glucose monitor or use of a glucose sensor * Have the ability to understand and be able to adhere to the proposed interventions. * Complete a detailed 3-day food record for one week prior to the intervention and record episodes of hypoglycemia (\<70 mg/dL) and hyperglycemia (\>180 mg/dL) * Able and willing to provide written informed consent and comply with the requirements of the study protocol. Exclusion Criteria: * Individuals with glycated hemoglobin ≥ 11% * Individuals who are using NPH insulin * Retinopathy with vision deficit that limits the activities proposed in the disciplines. * Individuals with gastrointestinal disease such as celiac disease, Crohn's disease and Irritable Bowel Syndrome (IBS) * History of bariatric surgery * That you are following a carbohydrate, protein and/or fat restriction diet * Individuals with BMI ≥ 40kg/m2 * Chronic kidney disease with estimated glomerular filtration \<30mL/min per 1.73 m2. * Liver failure or chronic viral hepatitis * Active or progressive neurodegenerative disease * Use of medications that affect glucose metabolism (corticosteroids and immunosuppressants) or cause weight loss. ● Treatment with weight-reducing agents (e.g., orlistat, sibutramine, topiramate, liraglutide) in the last 12 weeks prior to screening. * Treatment with thyroid hormone that has not been maintained at a stable dose in the last 12 weeks prior to screening. * History of active substance abuse (including alcohol) in the last year. * Serious psychiatric illness: Mood disorders, anxiety disorders, severe psychotic disorders, and personality disorders that are revealed or identified in the clinical evaluation, listed or reported in the medical record, and that have no clinical findings. * Predisposition to or diagnosis of eating disorders. * Women who are pregnant, intending to become pregnant during the study period, or who are breastfeeding. * Hyperglycemia characterized by acute symptoms: polyuria, polydipsia, and/or weight loss in the last 3 months. ● Metabolic and acute complications of diabetes such as ketoacidosis or hyperosmolar coma. * Night workers who work after 10 pm.

Locations (1)

Hospital de Clínicas de Porto Alegre

Porto Alegre, Brazil